XCUR
Exicure, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website exicuretx.com
- Employees(FY) 7
- ISIN US30205M2008
Performance
+6.86%
1W
-21.97%
1M
-17.11%
3M
-12.3%
6M
-14.61%
YTD
-51.89%
1Y
Profile
Exicure, Inc., an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.
Technical Analysis of XCUR 2024-05-10
Overview:
In analyzing the technical indicators for XCUR over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Analysis:
- Moving Averages (MA): The 5-day MA has been consistently decreasing, indicating a dow...
Recent News & Updates
- 2024-05-16 09:52
XCUR Stock Earnings: Exicure Reported Results for Q3 2023(Investorplace)
- 2024-05-16 04:08
- 2024-04-22 04:01
- 2024-02-05 18:05
Exicure and Bluejay sign hepatitis treatment development deal(Pharmaceutical-business-review)
- 2024-02-05 03:01
- 2023-12-07 19:40
Why Is Exicure (XCUR) Stock Up 57% Today?(Investorplace)
- 2023-11-28 03:01
- 2023-08-22 21:48
- 2023-08-11 04:01
- 2023-07-14 04:01
- 2023-05-26 04:01
- 2023-05-19 04:01
- 2023-05-04 04:01
- 2023-04-26 19:00
- 2023-03-27 04:01
- 2023-02-24 04:10
- 2022-12-13 16:00
- 2022-11-14 03:01
- 2022-09-26 04:01
- 2022-08-31 19:00
- 2022-08-15 04:01
- 2022-07-20 04:01
- 2022-06-29 00:00
- 2022-05-27 04:01
- 2022-05-16 19:00
- 2022-05-16 04:01
- 2022-05-10 07:21
- 2022-05-08 19:00
- 2022-03-25 04:15
- 2022-02-03 22:25
Page 1 of 4
previousnext